Epidemiology and Pathophysiology of Childhood Narcolepsy.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic, genetic, and observational findings without systematic search criteria or primary data.
PubMed 28108192 · doi:10.1016/j.prrv.2016.12.005
What was done
This narrative review summarizes current knowledge regarding the classification, genetic associations, immune mechanisms, and environmental triggers involved in childhood narcolepsy.
What was found
The abstract provides a descriptive overview without specific quantitative metrics or effect sizes. It notes that narcolepsy type 1 is caused by hypocretin (orexin) neuron loss, whereas narcolepsy type 2 features normal hypocretin levels and an unknown etiology. The HLA-DQB1*0602 allele is present in most patients with type 1 and approximately half of patients with type 2. In addition, the review describes associations between childhood narcolepsy onset and H1N1 influenza, noting spikes linked to Pandemrix vaccination in Europe, natural influenza infection in China, and early-onset increases observed in the United States.
Why it matters
It outlines how specific genetic immune profiles and environmental triggers—such as particular vaccines or viral infections—converge to cause pediatric narcolepsy, aiding clinical recognition of early-onset disease.
Limits
As a narrative review, it lacks a systematic literature search methodology, quality assessment of cited studies, and quantitative meta-analytic data. Specific effect sizes, incidence rates, and sample sizes are omitted in the abstract.
Cited by
- supports A flu vaccine administered in Europe around 2009-2010 was found to be associated with an increased risk of narcolepsy, hypothesized to be caused by cross-reactivity against hypocretin-producing neurons.